Literature DB >> 18556640

Estimating EuroQol EQ-5D scores from Population Healthy Days data.

Haomiao Jia1, Erica I Lubetkin.   

Abstract

BACKGROUND: Preference-based assessments of population health, which may be used for cost-utility analyses, are lacking for most states and communities. With adequate population data, preference-based values can be estimated from non-preference-based health-related quality of life (HRQOL) data. This study estimates scores on the EuroQol EQ-5D, a preference-based measure, from the Healthy Days
METHODS: No data set from the US population asks both the Healthy Days and EQ-5D questions for the same respondents. Therefore, estimates for EQ-5D scores were obtained indirectly by matching cumulative distributions of the 2 measures. These distributions were estimated from the 2000- 2002 Behavioral Risk Factor Surveillance System (BRFSS) and the Medical Expenditure Panel Survey (MEPS). The validity of estimates was examined by comparing the mean estimated and observed scores across particular population subgroups. A simulation study was conducted to compare the performance of the proposed method to the regression method.
RESULTS: The overall mean observed EQ-5D index was 0.871 and the mean estimated EQ-5D index was 0.872. In the majority of examined subgroups, the mean scores demonstrated a good match according to sociodemographic variables and health-related conditions and, with the exception of the most impaired health states, the differences tended to be less than 0.04.
CONCLUSIONS: This study provided preliminary estimates of EQ-5D scores from the Healthy Days Measures and demonstrated acceptable validity of the estimates. Because the Healthy Days Measures have been included in many state and local surveys, preliminary cost-utility analyses and determination of burden of disease might be able to be conducted at the national, state, and community levels as well as over time.

Mesh:

Year:  2008        PMID: 18556640     DOI: 10.1177/0272989X07312708

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  23 in total

1.  Quality-adjusted life expectancy (QALE) loss due to smoking in the United States.

Authors:  Haomiao Jia; Matthew M Zack; William W Thompson; Shanta R Dube
Journal:  Qual Life Res       Date:  2012-02-18       Impact factor: 4.147

2.  State Quality-Adjusted Life Expectancy for U.S. adults from 1993 to 2008.

Authors:  Haomiao Jia; Matthew M Zack; William W Thompson
Journal:  Qual Life Res       Date:  2011-01-06       Impact factor: 4.147

3.  Impact of depression on quality-adjusted life expectancy (QALE) directly as well as indirectly through suicide.

Authors:  Haomiao Jia; Matthew M Zack; William W Thompson; Alex E Crosby; Irving I Gottesman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-02-07       Impact factor: 4.328

4.  Health-related quality of life, quality-adjusted life years, and quality-adjusted life expectancy in new york city from 1995 to 2006.

Authors:  Erica I Lubetkin; Haomiao Jia
Journal:  J Urban Health       Date:  2009-03-13       Impact factor: 3.671

5.  A pragmatic community-based intervention of multimodal physiotherapy plus deep water running (DWR) for fibromyalgia syndrome: a pilot study.

Authors:  Antonio I Cuesta-Vargas; Nicola Adams
Journal:  Clin Rheumatol       Date:  2011-08-25       Impact factor: 2.980

6.  Impact of nine chronic conditions for US adults aged 65 years and older: an application of a hybrid estimator of quality-adjusted life years throughout remainder of lifetime.

Authors:  Haomiao Jia; Erica I Lubetkin
Journal:  Qual Life Res       Date:  2016-01-18       Impact factor: 4.147

7.  Impact of a community-based lifestyle intervention program on health-related quality of life.

Authors:  Yvonne L Eaglehouse; Gerald L Schafer; Vincent C Arena; M Kaye Kramer; Rachel G Miller; Andrea M Kriska
Journal:  Qual Life Res       Date:  2016-02-20       Impact factor: 4.147

8.  The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy.

Authors:  Haomiao Jia; Matthew M Zack; William W Thompson
Journal:  Value Health       Date:  2012-11-30       Impact factor: 5.725

9.  Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season.

Authors:  Fiona Havers; Swathi Thaker; Jessie R Clippard; Michael Jackson; Huong Q McLean; Manjusha Gaglani; Arnold S Monto; Richard K Zimmerman; Lisa Jackson; Josh G Petrie; Mary Patricia Nowalk; Krissy K Moehling; Brendan Flannery; Mark G Thompson; Alicia M Fry
Journal:  Clin Infect Dis       Date:  2014-07-16       Impact factor: 9.079

10.  Breast Cancer in Young Women: Health State Utility Impacts by Race/Ethnicity.

Authors:  Justin G Trogdon; Donatus U Ekwueme; Linda Chamiec-Case; Gery P Guy
Journal:  Am J Prev Med       Date:  2016-02       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.